Top Institutions in Ophthalmology - Dry Eye Disease and Ocular Pharmacology
Institutions were ranked based on their known leadership in ophthalmic research, particularly in dry eye disease, ocular surface pharmacology, and clinical trials involving cyclosporine and other immunomodulatory therapies. Consideration was given to centers with strong translational research programs and collaborations with industry for drug development and patient access initiatives.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in ophthalmic research, with extensive clinical trials and translational research focused on dry eye disease and novel ocular pharmacotherapies including cyclosporine formulations.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with a strong focus on corneal diseases and dry eye research, including clinical trials of novel topical immunomodulators.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a long-standing reputation for innovation in ocular immunology and dry eye disease, contributing to the understanding and development of cyclosporine-based therapies.
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF is recognized for its comprehensive dry eye disease research program and expertise in ocular pharmacology, including novel drug delivery systems for cyclosporine.
-
#5
Duke University Eye Center
Durham, NC
Duke Eye Center has a robust clinical research infrastructure with a focus on dry eye disease and ocular surface inflammation, contributing to advancements in cyclosporine therapy and patient access programs.